Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism With Multiple Sclerosis in Turkish Patients.
Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
Neural networks to identify multiple sclerosis with optical coherence tomography.
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Masquerading optic neuritis.
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
A case of hereditary diffuse leukoencephalopathy with axonal spheroids caused by a de novo mutation in CSF1R masquerading as primary progressive multiple sclerosis.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
How I treat POEMS syndrome.
Present and emerging therapies for multiple sclerosis.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
Fingolimod May Protect Neurons from Degeneration
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.
Neurological and psychiatric disorders as a neuroglial failure.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Internal jugular and vertebral vein volume flow in patients with clinically isolated syndrome or mild multiple sclerosis and healthy controls: results from a prospective sonographer-blinded study.
Association between Smoking and Health Outcomes in Postmenopausal Women Living with Multiple Sclerosis.
Protective effects of N-acetyl-L-cysteine in human oligodendrocyte progenitor cells and restoration of motor function in neonatal rats with hypoxic-ischemic encephalopathy.
Dysfunction in Motor Coordination in Neonatal White Matter Injury Model without Apparent Neuron Loss.
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation.
Serum Arsenic and Lipid Peroxidation Levels in Patients with Multiple Sclerosis.
CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Pages
« first
‹ previous
…
448
449
450
451
452
453
454
455
456
…
next ›
last »